From January 1, 2023 to February 17, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 103,145 shares, representing 0.64% for $1.03 million under the buyback announced on July 26, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.61 USD | -.--% | -10.66% | +1.99% |
Apr. 16 | Health Care Ticks Up After UnitedHealth Earnings -- Health Care Roundup | DJ |
Apr. 16 | ProPhase Labs, Inc. Unveils Project ZenQ-AI | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.99% | 83.19M | |
-17.86% | 8.35B | |
+39.49% | 3.58B | |
-38.71% | 2.46B | |
-8.06% | 2.47B | |
-7.96% | 2.36B | |
-13.97% | 1.78B | |
-19.73% | 1.53B | |
-40.78% | 1.21B | |
+8.32% | 1.12B |
- Stock Market
- Equities
- PRPH Stock
- News ProPhase Labs, Inc.
- Tranche Update on ProPhase Labs, Inc.'s Equity Buyback Plan announced on July 26, 2022.